James N. Topper - Director, 10%+ Owner at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

James N. Topper - trading volume in the past year for Phathom Pharmaceuticals, Inc.

Holdings reported by James N. Topper for Phathom Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.83M $19.3M $3.31 Jun 3, 2025 By Frazier Life Sciences IX, L.P.
Common Stock 59.4K $197K $3.31 Jun 3, 2025 By Frazier Life Sciences X, L.P.
Common Stock 42.6K $141K $3.31 Jun 3, 2025 Direct
Common Stock 3.91K $12.9K $3.31 Jun 3, 2025 By Topper Group III LLC
Common Stock 1 $3.00 $3.31 Jun 3, 2025 By FHMLS IX, L.L.C.
Stock Option (Right to Buy) 17.5K Jun 3, 2025 Direct Common Stock

Transactions reported by James N. Topper for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.